ChatGPT-Supported Text Messaging Program for Smoking Cessation

Part of paid clinical trials in Washington D.C., District of Columbia.

Sponsor
George Washington University
Study ID
NCT07079306
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Smoking Cessation

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • BeFree+Bot — BEHAVIORAL
    Text messaging program called BeFree and access to BBot, ChatGPT chatbot
  • BeFree — BEHAVIORAL
    Text messaging program called BeFree

Study Details

The current research proposal aims to explore how a purpose driven LLM ChatGPT chatbot, BeFreeBot, might enhance an evidence-based text messaging smoking cessation program, BeFree. The research will consist of a formative evaluation comparing quitting related outcomes among users of BeFree+Bot and BeFree.

Key Dates

Start date
Oct 1, 2026
Status verified
May 2026
Primary completion
Dec 30, 2026
Completion
Jan 30, 2027

Study Design

Enrollment
150 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Intervention
    Text messages about quitting smoking and access to specialized ChatGPT chatbot
  • Active Comparator: Control
    Text messages about quitting smoking

Primary Outcome Measure

Continuous abstinence [ Time Frame: at 1 month follow-up ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
ProlificWashington D.C.District of Columbia20052-

Find similar trials in Washington D.C., DC

By research site
Prolific· Washington D.C., DC

Related Studies